These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5711605)

  • 21. [Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline].
    Haas H; Igarashi T
    Arzneimittelforschung; 1968 Nov; 18(11):1373-80. PubMed ID: 5755900
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of various antiarrhythmic drugs on the daunomycin-induced arrhythmia in the hamster.
    Herman EH; Schein P; Taylor O; Waravdekar VS
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):69-72. PubMed ID: 5412364
    [No Abstract]   [Full Text] [Related]  

  • 23. Steric aspects of adrenergic drugs. 8. Optical isomers of beta adrenergic receptor antagonists.
    Patil PN
    J Pharmacol Exp Ther; 1968 Apr; 160(2):308-14. PubMed ID: 4384787
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanism of action of a new adrenergic beta-receptor antagonist MJ 1999 in the prevention of halothane-adrenaline-induced and ouabain-induced ventricular tachycardia in the dog.
    Sharma PL
    Indian J Med Res; 1967 Dec; 55(12):1357-65. PubMed ID: 5595584
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of haemodynamic effects of oxprenolol (trasicor), alprenolol (aptin), and sotalol (MJ 1999) in man.
    Gibson DG; Hoy J; Sowton E
    Br Heart J; 1970 Jul; 32(4):553. PubMed ID: 4393535
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of pindolol on the metabolic activities of adrenaline].
    Schmitt H; Lucet B
    C R Seances Soc Biol Fil; 1970; 164(11):2193-5. PubMed ID: 4399994
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 29. A nerve-blocking action of MJ-1999.
    Bartlet AL; Hassan T
    Br J Pharmacol; 1969 May; 36(1):176P-177P. PubMed ID: 5813957
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M; Imamura H; Nakamura T
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome.
    Shimizu W; Ohe T; Kurita T; Kawade M; Arakaki Y; Aihara N; Kamakura S; Kamiya T; Shimomura K
    J Am Coll Cardiol; 1995 Nov; 26(5):1299-309. PubMed ID: 7594047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
    Flórez J; Arconada JA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential (beta blockade and the cardiac action potential).
    Coltart DJ; Meldrum SJ
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):188-97. PubMed ID: 4398411
    [No Abstract]   [Full Text] [Related]  

  • 35. A critical evaluation of three methods for the study of adrenergic beta-blocking and anti-arrhythmic agents.
    Vargaftig B; Coignet JL
    Eur J Pharmacol; 1969 Apr; 6(1):49-55. PubMed ID: 4389065
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative action of propranolol and sotalol (MJ-1999) on myocardial oxygen consumption in dogs: hemodynamic correlates.
    Levy JV
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):114-9. PubMed ID: 4391634
    [No Abstract]   [Full Text] [Related]  

  • 39. Propranolol (Inderal) in experimentally-induced cardiac arrhythmias.
    Lucchesi BR; Whitsitt LS; Brown NL
    Can J Physiol Pharmacol; 1966 Jul; 44(4):543-7. PubMed ID: 5966564
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative study of some cardiovascular effects of sotalol (MJ 1999) and propranolol.
    Aberg G; Dzedin T; Lundholm L; Olsson L; Svedmyr N
    Life Sci; 1969 Apr; 8(7):353-65. PubMed ID: 5769443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.